You have 9 free searches left this month | for more free features.

metformin combination

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oral Leukoplakia Trial in Minneapolis (pioglitazone-metformin)

Not yet recruiting
  • Oral Leukoplakia
  • Minneapolis, Minnesota
    University of Minnesota
Feb 4, 2023

Polycystic Ovary Syndrome, Obesity, Infertility, Female Trial (Liraglutide + Metformin, Metformin)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • +2 more
  • (no location specified)
Jul 10, 2023

Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)

Active, not recruiting
  • Prostate Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 4, 2022

Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg

Not yet recruiting
  • Type2diabetes
  • Insulin Resistance
  • (no location specified)
Oct 20, 2022

Obesity, Childhood, Insulin Resistance Trial in Edmonton (Metformin 850 mg oral tablet bid, Supplemental fiber mixture (35 g

Recruiting
  • Obesity, Childhood
  • Insulin Resistance
  • Metformin 850 mg oral tablet bid
  • Supplemental fiber mixture (35 g total) composed of 6g of Oligofructose + 12g of resistant maltodextrin + 12g of acacia gum + 5g of PGX.
  • Edmonton, Alberta, Canada
    University of Alberta
Apr 1, 2022

PCO Trial in Peshawar (OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD), Metformin (1000 mg Twice a day))

Recruiting
  • PCO
  • OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD)
  • Metformin (1000 mg Twice a day)
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Gynecology and Obstetric, Hayatabad Medical Complex
Jul 19, 2023

Advanced Cancers Trial in Houston (Temsirolimus, Metformin)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Preeclampsia Severe, Preeclampsia Second Trimester, Preterm Birth Complication Trial in Newark (Esomeprazole 20mg)

Not yet recruiting
  • Preeclampsia Severe
  • +2 more
  • Esomeprazole 20mg
  • Newark, Delaware
    Christiana Care Health Systems
Nov 2, 2022

Healthy Subjects Trial in Cheongju-si (DW6013)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
May 16, 2023

Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • New York, New York
    Columbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022

Healthy Subjects Trial in Cheongju-si (DW6013)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
May 16, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Jacksonville, Florida
  • +1 more
Jan 5, 2023

Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Glucose, High Blood
  • Cheonju, Chungcheongbuk-do, Korea, Republic of
    Chungbuk National University Hospital
Jul 19, 2022

Poly Cystic Ovary Syndrome Trial (Daflon, Combined oral contraceptive, Metformin)

Not yet recruiting
  • Poly Cystic Ovary Syndrome
  • (no location specified)
Oct 9, 2023

Type 2 Diabetes Trial in Beijing (Retagliptin phosphate tablets?metformin sustained-release tablets, Retagliptin phosphate

Recruiting
  • Type 2 Diabetes
  • Retagliptin phosphate tablets、metformin sustained-release tablets
  • Retagliptin phosphate placebo tablets、metformin sustained-release tablets
  • Beijing, Beijing, China
    Beijing Hospital
Jun 9, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)

Not yet recruiting
  • Diabetes Mellitus
  • +4 more
  • (no location specified)
Aug 16, 2022

Diabetes Trial in India (Canagliflozin + Metformin HCl (Fixed Dose Combination))

Completed
  • Diabetes Mellitus
  • Canagliflozin + Metformin hydrochloride (Fixed Dose Combination)
  • Bengaluru, India
  • +9 more
Aug 16, 2022

Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,

Completed
  • Healthy Volunteer
  • Dapagliflozin/metformin XR FDC 5/500 mg
  • +3 more
  • Suzhou, China
    Research Site
Apr 25, 2022

Learn More About How Acarbose and Metformin Work When Taken

Recruiting
  • Type 2 Diabetes Mellitus
  • BAY81-9783 (Acarbose/Metformin)
  • Multiple Locations, India
    Many locations
Aug 10, 2022

Diabetes, Type 2 Trial in Maysan Governorate (drug, combination product, other)

Completed
  • Diabetes Mellitus, Type 2
  • Metformin 500 mg/day
  • +2 more
  • Maysan Governorate, Iraq
    Maysan Centre for Diabetes and Endocrinology
Jun 15, 2023

Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Nov 2, 2022

Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)

Recruiting
  • Multiple Sclerosis
  • Metformin and clemastine in combination
  • Placebo
  • Cambridge, United Kingdom
    Addenbrooke's Hospital
Jun 14, 2022

Uveitis, Metformin, Glucocorticoid Trial in Tianjin (Metformin, Placebo)

Recruiting
  • Uveitis
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Eye Hospital
May 5, 2022